| Literature DB >> 36087339 |
Giacomo De Giorgi1,2,3,4, Pascal Geldsetzer5,6, Felix Michalik7, M Maddalena Speziali1,8.
Abstract
BACKGROUND: Whereas there is strong evidence that wearing a face mask is effective in reducing the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), evidence on the impact of mandating the wearing of face masks on deaths from coronavirus disease 2019 (COVID-19) and all-cause mortality is more sparse and likely to vary by context. Focusing on a quasi-experimental setting in Switzerland, we aimed to determine (i) the effect of face-mask mandates for indoor public spaces on all-cause mortality; and (ii) how the effect has varied over time, and by age and sex.Entities:
Mesh:
Year: 2022 PMID: 36087339 PMCID: PMC9527954 DOI: 10.1093/eurpub/ckac123
Source DB: PubMed Journal: Eur J Public Health ISSN: 1101-1262 Impact factor: 4.424
Results of the Difference-in-Differences regressions
| (1) | (2) | (3) | (4) | (5) | (6) | (7) | (8) | (9) | |
|---|---|---|---|---|---|---|---|---|---|
| Variables | Male | Male | Male | Female | Female | Female | Total | Total | Total |
| Treat | −0.070 | −0.009*** | −0.009*** | −0.055 | 0.066*** | 0.066*** | −0.063 | 0.026*** | 0.026*** |
| (0.049) | (0.001) | (0.001) | (0.055) | (0.001) | (0.001) | (0.051) | (0.001) | (0.001) | |
| Post | −0.046** | −0.045** | 0.010 | −0.116*** | −0.115*** | −0.024 | −0.082*** | −0.081*** | −0.007 |
| (0.018) | (0.018) | (0.026) | (0.013) | (0.014) | (0.018) | (0.013) | (0.013) | (0.020) | |
| DiD | −0.031 | −0.031 | −0.031 | 0.024 | 0.024 | 0.023 | −0.003 | −0.003 | −0.003 |
| (0.020) | (0.020) | (0.021) | (0.021) | (0.021) | (0.021) | (0.015) | (0.015) | (0.015) | |
| Constant | 2.705*** | 2.617*** | 2.697*** | 2.741*** | 2.622*** | 2.778*** | 2.733*** | 2.625*** | 2.744*** |
| (0.041) | (0.001) | (0.014) | (0.045) | (0.001) | (0.017) | (0.042) | (0.001) | (0.012) | |
| Observations | 9168 | 9168 | 9168 | 9178 | 9178 | 9178 | 9329 | 9329 | 9329 |
|
| 0.021 | 0.190 | 0.286 | 0.016 | 0.225 | 0.371 | 0.026 | 0.291 | 0.462 |
| Year FE | No | No | Yes | No | No | Yes | No | No | Yes |
| Canton FE | No | Yes | Yes | No | Yes | Yes | No | Yes | Yes |
| Week FE | No | No | Yes | No | No | Yes | No | No | Yes |
| Mean | 2.686 | 2.686 | 2.686 | 2.719 | 2.719 | 2.719 | 2.708 | 2.708 | 2.708 |
Note: Results of regression based on Equation (1); weighted using population as analytical weights. Column 1-2-3 contain observations for male population. Columns 4-5-6 contain observations for the female population. Column 7-8-9 contain observations for aggregate male and female population. S.E. clustered at a canton level (***P < 0.01, **P < 0.05, *P < 0.1). Period of estimation: between January 2012 and 4 October 2020. Treated cantons are those that between July 7 and October 4 have imposed any mask requirement other than Federal indications (e.g. in supermarkets, restaurants, open space): BS, FR, GE, JU, NE, SO, VS, VD, ZH. Post is equal to 1 for all cantons after July 7.
Figure 1Effect of the face-mask mandate on all-cause mortality using an event-study approach.
Note: Estimates of Equation (2), weighted using population as analytical weights. Point estimates are displayed along with their 95% confidence intervals. The percentage difference in all-cause mortality is approximated by the log. Baseline period for the analysis: 1 week prior to implementation of the face-mask mandate in each canton, indicated by the vertical line in the plot.
Figure 2Variation in the effect of the face-mask mandate by time since implementation
Note: The dots indicate the estimated β2 in week w as in Equation (7), weighted using population as analytical weights. The percentage difference in all-cause mortality is approximated by the log. Week 1 is the first week after the treatment, until the 13th week. Outcome defined as Supplementary equation (S1). Each vertical bar represents the respective 95% confidence interval.
Figure 3Effect of the face-mask mandate on COVID-19 cases and deaths over time
Note: The dots indicate the estimated β2 in week w; weighted using population as analytical weights. The percentage difference is approximated by the log. Week 1 is the first week after the treatment, until the 13th week. Outcome defined as Supplementary equations (S4) and (S5), respectively. Each vertical bar represents the respective 95% confidence interval.